nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL13—psoriasis	0.00524	0.00524	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00512	0.00512	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—CCL20—psoriasis	0.00486	0.00486	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HCAR2—psoriasis	0.0045	0.0045	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	0.00446	0.00446	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00438	0.00438	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HCAR2—psoriasis	0.00424	0.00424	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—CCL20—psoriasis	0.00413	0.00413	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HCAR2—psoriasis	0.00408	0.00408	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—CCL20—psoriasis	0.0039	0.0039	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00387	0.00387	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HCAR2—psoriasis	0.00385	0.00385	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.0038	0.0038	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00378	0.00378	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.00368	0.00368	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—LEP—psoriasis	0.00366	0.00366	CbGpPWpGaD
Minaprine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.00365	0.00365	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HCAR2—psoriasis	0.00363	0.00363	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	0.00341	0.00341	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CCL20—psoriasis	0.00334	0.00334	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HCAR2—psoriasis	0.0033	0.0033	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL10—psoriasis	0.00328	0.00328	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HCAR2—psoriasis	0.0032	0.0032	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	0.00319	0.00319	CbGpPWpGaD
Minaprine—ACHE—ATF-2 transcription factor network—IL6—psoriasis	0.00317	0.00317	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—HCAR2—psoriasis	0.00315	0.00315	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HCAR2—psoriasis	0.00313	0.00313	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NDUFA5—psoriasis	0.00311	0.00311	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.00309	0.00309	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—REN—psoriasis	0.00309	0.00309	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.00298	0.00298	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—LEP—psoriasis	0.00296	0.00296	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CCL20—psoriasis	0.00294	0.00294	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NDUFA5—psoriasis	0.00293	0.00293	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HCAR2—psoriasis	0.00291	0.00291	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.0029	0.0029	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CCL20—psoriasis	0.0029	0.0029	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CCL20—psoriasis	0.00288	0.00288	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HCAR2—psoriasis	0.00286	0.00286	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HCAR2—psoriasis	0.00285	0.00285	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	0.00277	0.00277	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—NOS2—psoriasis	0.00276	0.00276	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.00267	0.00267	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP2S1—psoriasis	0.00264	0.00264	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—PPARG—psoriasis	0.00258	0.00258	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP2S1—psoriasis	0.00249	0.00249	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.00244	0.00244	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.00242	0.00242	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HCAR2—psoriasis	0.00241	0.00241	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CCL20—psoriasis	0.00234	0.00234	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HCAR2—psoriasis	0.00228	0.00228	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00227	0.00227	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	0.00227	0.00227	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	0.00226	0.00226	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—LEP—psoriasis	0.00224	0.00224	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CCL20—psoriasis	0.0022	0.0022	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—LEP—psoriasis	0.00219	0.00219	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.00218	0.00218	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCL20—psoriasis	0.00212	0.00212	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TAGAP—psoriasis	0.00209	0.00209	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—NOS2—psoriasis	0.00209	0.00209	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	0.00207	0.00207	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.00205	0.00205	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—NOS2—psoriasis	0.00204	0.00204	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCL20—psoriasis	0.002	0.002	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.00198	0.00198	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TAGAP—psoriasis	0.00197	0.00197	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.00197	0.00197	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—PPARG—psoriasis	0.00195	0.00195	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HCAR2—psoriasis	0.00195	0.00195	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—ACE—psoriasis	0.00193	0.00193	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—PPARG—psoriasis	0.00191	0.00191	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CCL20—psoriasis	0.00188	0.00188	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00183	0.00183	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—JUN—psoriasis	0.00183	0.00183	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.00179	0.00179	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.00179	0.00179	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HCAR2—psoriasis	0.00172	0.00172	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCL20—psoriasis	0.00171	0.00171	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	0.0017	0.0017	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HCAR2—psoriasis	0.00169	0.00169	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TAGAP—psoriasis	0.00169	0.00169	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HCAR2—psoriasis	0.00168	0.00168	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	0.00167	0.00167	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—JUN—psoriasis	0.00167	0.00167	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CCL20—psoriasis	0.00166	0.00166	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CCL20—psoriasis	0.00164	0.00164	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CCL20—psoriasis	0.00163	0.00163	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.0016	0.0016	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00159	0.00159	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00158	0.00158	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.00153	0.00153	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCL20—psoriasis	0.00151	0.00151	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	0.00149	0.00149	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TAGAP—psoriasis	0.00149	0.00149	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCL20—psoriasis	0.00149	0.00149	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCL20—psoriasis	0.00148	0.00148	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00147	0.00147	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TAGAP—psoriasis	0.00147	0.00147	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TAGAP—psoriasis	0.00146	0.00146	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.00146	0.00146	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.00138	0.00138	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—JUN—psoriasis	0.00138	0.00138	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00138	0.00138	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	0.00137	0.00137	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	0.00137	0.00137	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—JUN—psoriasis	0.00135	0.00135	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.00135	0.00135	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	0.00131	0.00131	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CARM1—psoriasis	0.00129	0.00129	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NDUFA5—psoriasis	0.00127	0.00127	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCL20—psoriasis	0.00125	0.00125	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	0.00125	0.00125	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CARM1—psoriasis	0.00122	0.00122	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—TP53—psoriasis	0.00121	0.00121	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.00121	0.00121	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—LEP—psoriasis	0.0012	0.0012	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00118	0.00118	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL20—psoriasis	0.00118	0.00118	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—CXCL8—psoriasis	0.00112	0.00112	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.00111	0.00111	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—IL6—psoriasis	0.00111	0.00111	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP2S1—psoriasis	0.00108	0.00108	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—CXCL8—psoriasis	0.00105	0.00105	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00104	0.00104	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00103	0.00103	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00102	0.00102	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL20—psoriasis	0.00101	0.00101	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	0.00101	0.00101	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—TP53—psoriasis	0.000913	0.000913	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CXCL8—psoriasis	0.000901	0.000901	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000897	0.000897	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—TP53—psoriasis	0.000893	0.000893	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL20—psoriasis	0.000892	0.000892	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL20—psoriasis	0.000878	0.000878	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL20—psoriasis	0.000873	0.000873	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—IL6—psoriasis	0.000836	0.000836	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—IL6—psoriasis	0.000818	0.000818	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—CXCL8—psoriasis	0.000795	0.000795	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CXCL8—psoriasis	0.000795	0.000795	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CAT—psoriasis	0.000794	0.000794	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CXCL8—psoriasis	0.000782	0.000782	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000779	0.000779	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CXCL8—psoriasis	0.000778	0.000778	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.000775	0.000775	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CAT—psoriasis	0.000748	0.000748	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SOCS1—psoriasis	0.00069	0.00069	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TYK2—psoriasis	0.000658	0.000658	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SOCS1—psoriasis	0.000651	0.000651	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	0.000631	0.000631	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TYK2—psoriasis	0.000621	0.000621	CbGpPWpGaD
Minaprine—ACHE—Metabolism—APOE—psoriasis	0.000617	0.000617	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	0.000595	0.000595	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOE—psoriasis	0.000581	0.000581	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CXCL8—psoriasis	0.000573	0.000573	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SOCS1—psoriasis	0.000557	0.000557	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CXCL8—psoriasis	0.00054	0.00054	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PPARG—psoriasis	0.000537	0.000537	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TYK2—psoriasis	0.000531	0.000531	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CARM1—psoriasis	0.000529	0.000529	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOE—psoriasis	0.000509	0.000509	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—LEP—psoriasis	0.000509	0.000509	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	0.000509	0.000509	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PPARG—psoriasis	0.000506	0.000506	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SOCS1—psoriasis	0.000491	0.000491	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SOCS1—psoriasis	0.000483	0.000483	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SOCS1—psoriasis	0.000481	0.000481	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOE—psoriasis	0.00048	0.00048	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—LEP—psoriasis	0.00048	0.00048	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	0.000475	0.000475	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TYK2—psoriasis	0.000468	0.000468	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	0.000462	0.000462	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TYK2—psoriasis	0.000461	0.000461	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TYK2—psoriasis	0.000459	0.000459	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	0.000449	0.000449	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NFKBIA—psoriasis	0.000448	0.000448	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	0.000442	0.000442	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	0.00044	0.00044	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—LEP—psoriasis	0.000411	0.000411	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—psoriasis	0.000411	0.000411	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CXCL8—psoriasis	0.000408	0.000408	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	0.000401	0.000401	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	0.000399	0.000399	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TYK2—psoriasis	0.000389	0.000389	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	0.000383	0.000383	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TYK2—psoriasis	0.000367	0.000367	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LEP—psoriasis	0.000363	0.000363	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—psoriasis	0.000363	0.000363	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—psoriasis	0.000357	0.000357	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LEP—psoriasis	0.000357	0.000357	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LEP—psoriasis	0.000355	0.000355	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—psoriasis	0.000355	0.000355	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL8—psoriasis	0.000338	0.000338	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NFKBIA—psoriasis	0.000338	0.000338	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	0.000332	0.000332	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	0.000331	0.000331	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CAT—psoriasis	0.000326	0.000326	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—psoriasis	0.000322	0.000322	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—psoriasis	0.000319	0.000319	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—JUN—psoriasis	0.000315	0.000315	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TYK2—psoriasis	0.000314	0.000314	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—psoriasis	0.000303	0.000303	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NFKB1—psoriasis	0.000303	0.000303	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—JUN—psoriasis	0.000297	0.000297	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NFKB1—psoriasis	0.000286	0.000286	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TYK2—psoriasis	0.000277	0.000277	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—psoriasis	0.000275	0.000275	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—psoriasis	0.000273	0.000273	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TYK2—psoriasis	0.000272	0.000272	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—psoriasis	0.000272	0.000272	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TYK2—psoriasis	0.000271	0.000271	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—psoriasis	0.00026	0.00026	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—psoriasis	0.000259	0.000259	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—psoriasis	0.000257	0.000257	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—JUN—psoriasis	0.000254	0.000254	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—psoriasis	0.000253	0.000253	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NFKB1—psoriasis	0.000244	0.000244	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—psoriasis	0.000241	0.000241	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—psoriasis	0.000237	0.000237	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—psoriasis	0.000236	0.000236	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—psoriasis	0.000229	0.000229	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—psoriasis	0.000225	0.000225	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—psoriasis	0.000224	0.000224	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—JUN—psoriasis	0.000224	0.000224	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—psoriasis	0.000222	0.000222	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—JUN—psoriasis	0.00022	0.00022	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—psoriasis	0.00022	0.00022	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—psoriasis	0.00022	0.00022	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—JUN—psoriasis	0.000219	0.000219	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NFKB1—psoriasis	0.000216	0.000216	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NFKB1—psoriasis	0.000212	0.000212	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NFKB1—psoriasis	0.000211	0.000211	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—psoriasis	0.000208	0.000208	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—psoriasis	0.000196	0.000196	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—psoriasis	0.000196	0.000196	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—psoriasis	0.000194	0.000194	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—psoriasis	0.000193	0.000193	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—psoriasis	0.000192	0.000192	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—psoriasis	0.000191	0.000191	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—psoriasis	0.00019	0.00019	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—psoriasis	0.00019	0.00019	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—psoriasis	0.000179	0.000179	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—psoriasis	0.000168	0.000168	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—psoriasis	0.000153	0.000153	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—psoriasis	0.000148	0.000148	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—psoriasis	0.000146	0.000146	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—psoriasis	0.000145	0.000145	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—psoriasis	0.000135	0.000135	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—psoriasis	0.000133	0.000133	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—psoriasis	0.000132	0.000132	CbGpPWpGaD
